Valvular & structural heart disease

Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement

JACC AdvPublished Medicare Provider Analysis and Review file from fiscal year 2020

Authors' conclusion

In contemporary practice, approximately one in 3 Medicare TAVR patients experience serious complications, substantially increasing hospital resource use. Despite improvements in TAVR outcomes and efficiency, additional cost savings can be achieved through complication mitigation.

Study context

Population
Medicare beneficiaries undergoing transcatheter aortic valve replacement (TAVR)Medicare beneficiaries undergoing TAVR, fiscal year 2020
Participants
66,893 beneficiaries
Comparison
Patients who experience any of the complications compared to those not experiencing complications
Outcome
One or more complications
Follow-up
2020
Methodological detailsMultivariable regression
  • Multivariable regression

Main finding

As reported in the abstract

Experienced one or more complications

31.1%

Further findings

OutcomeEstimate
Incremental cost and LOS with any complicationComplications vs No complications · increased costsincremental cost $15,377
Incremental cost and LOS with any complicationComplications vs No complications · increasedincremental LOS 2.8 days
Incremental cost and LOS with any complicationComplications vs No complications · After adjustments for patient risk factorsrisk-adjusted incremental cost $12,953

Cost and length of stay (LOS) of TAVR hospitalization

Mean cost of a TAVR hospitalization
$54,988 ± $26,744
Mean LOS
3.1 ± 4.5 days

Highest risk-adjusted costs by complication

Surgical aortic valve replacement
$42,924
Acute renal failure requiring dialysis
$34,606
In-hospital mortality
$25,307

Total additional costs from complications

Additional costs
$320 million
Share of total hospital cost for Medicare TAVR patients
8.7%

Original publication

Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement. JACC Adv. Published 26 August 2025. doi:10.1016/j.jacadv.2025.102107

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.